gliclazide has been researched along with Stomach Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Du, Y; Huang, S; Li, X; Lu, D; Nan, Y; Yang, Y; Yuan, L; Zhang, J; Zhang, L | 1 |
| Chen, Y; Du, YH; Li, X; Lu, DD; Ma, XL; Nan, Y; Niu, Y; Yang, Y; Yuan, L; Zhang, JF; Zhang, L | 1 |
| Cao, D; Cao, X; Jia, Z; Jiang, J; Oshima, M; Su, T; Tsukamoto, T; Wu, M; Wu, Y; Zhang, Y; Zhao, D | 1 |
| Cai, H; Chen, X; Wang, J; Zhang, J | 1 |
| Cao, D; Cao, X; Jia, Z; Jiang, J; Oshima, M; Tsukamoto, T; Wu, M; Wu, Y; Zhang, H; Zhang, Y; Zhao, D; Zhou, T | 1 |
| Cao, D; Cao, X; Hou, Z; Jia, Z; Jiang, J; Oshima, M; Suo, Y; Tsukamoto, T; Wen, S; Wu, Y; You, L; Zhang, H | 1 |
6 other study(ies) available for gliclazide and Stomach Neoplasms
| Article | Year |
|---|---|
Exploring the molecular mechanism of glycyrrhetinic acid in the treatment of gastric cancer based on network pharmacology and experimental validation.
Topics: Glycyrrhetinic Acid; Humans; Molecular Docking Simulation; Network Pharmacology; Proto-Oncogene Proteins p21(ras); Stomach Neoplasms | 2023 |
18β-glycyrrhetinic acid inhibits proliferation of gastric cancer cells through regulating the miR-345-5p/TGM2 signaling pathway.
Topics: Animals; Apoptosis; Autophagy-Related Proteins; Cell Division; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Mice; Mice, Nude; MicroRNAs; Proteomics; Signal Transduction; Stomach Neoplasms | 2023 |
Reactivation of Atp4a concomitant with intragenic DNA demethylation for cancer inhibition in a gastric cancer model.
Topics: Animals; Blotting, Western; Disease Models, Animal; DNA Methylation; Gene Expression Profiling; Gene Silencing; Glycyrrhetinic Acid; H(+)-K(+)-Exchanging ATPase; Humans; Mice; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms | 2020 |
18β-glycyrrhetinic acid inhibits migration and invasion of human gastric cancer cells via the ROS/PKC-α/ERK pathway.
Topics: Cell Movement; Glycyrrhetinic Acid; Humans; MAP Kinase Signaling System; Neoplasm Invasiveness; Reactive Oxygen Species; Stomach Neoplasms | 2018 |
18β-glycyrrhetinic acid inhibited mitochondrial energy metabolism and gastric carcinogenesis through methylation-regulated TLR2 signaling pathway.
Topics: Animals; Carcinogenesis; Cell Line; Cell Line, Tumor; Cell Proliferation; Energy Metabolism; Glycyrrhetinic Acid; Humans; Methylation; Mice; Mitochondria; Signal Transduction; Stomach; Stomach Neoplasms; Toll-Like Receptor 2 | 2019 |
18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling.
Topics: Adult; Aged; Animals; Apoptosis; Cell Line, Tumor; Cyclooxygenase 2; Female; Glycyrrhetinic Acid; Humans; Lymphatic Metastasis; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Middle Aged; Stomach Neoplasms; Wnt Signaling Pathway; Wnt1 Protein | 2016 |